# Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

> clinical trial · VERIFIED · 2026-06-26

Status: COMPLETED · Sponsor: Trisha Wise-Draper · Condition: Recurrent Head and Neck Cancer

- Company: Trisha Wise-Draper
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03691714

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.